Media Centre - Neurochase

VIVOLTA partners with Neurochase

DuncanarioNCH November 13, 2024 No Comments

VIVOLTA partners with Neurochase to manufacture electrospun micro-catheters delivering advanced CNS therapies to the brain Waalre, The Netherlands, 13 November 2024 – VIVOLTA, the medical electrospinning solutions provider, has signed a long-term partnership [...]

Spark Therapeutics Enters Into Strategic Collaboration with Neurochase

DuncanarioNCH January 18, 2024 No Comments

Original Article: Global News Wire Spark Therapeutics Enters Into Strategic Collaboration with Neurochase for Use of Proprietary Delivery Technology for CNS Disorders PHILADELPHIA, Jan. 27, 2023 (GLOBE NEWSWIRE) — Spark [...]

Novel Gene Therapy for Motor Neurone Disease (MND) & Parkinson’s (PD)

DuncanarioNCH January 18, 2024 No Comments

Innervate Therapeutics is a biotechnology company focused on developing glial cell -derived neurotrophic factor (GDNF) gene therapies to achieve neuro-restoration and neuroprotection in diseases including PD and MND. GDNF, a [...]

Brain Tumor Therapy – A New Indication For Hamlet Pharma

DuncanarioNCH January 18, 2024 No Comments

Original Article Today, Hamlet Pharma signed a joint development agreement with Neurochase Limited, founded by Professor Steven Gill, a world leading expert in the area of neurosurgery, to develop novel [...]

News & Articles

VIVOLTA partners with Neurochase

Spark Therapeutics Enters Into Strategic Collaboration with Neurochase

Novel Gene Therapy for Motor Neurone Disease (MND) & Parkinson’s (PD)

Brain Tumor Therapy – A New Indication For Hamlet Pharma